New cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) are rapidly evolving with the use of innovative materials and new technologies. While new concepts for cardiac technology are not lacking, successful commercialization is a skill that is also required. Business analysts from the healthcare market research firm Allied Market Research pick out five of the latest innovations in the cardiovascular medical implants segment that should be watched. They feel these technologies have the potential to disrupt the market as new standards for patient care.

(Editor's note: links to newer information and video links from recent conferences were added to this article in February 2017)

One of the more significant advancements for interventional X-ray (IXR) in the past few years has been an increased focus on core and supporting technologies to provide high-quality, high-resolution images without a corresponding increase in radiation dose. 

Automated external defibrillators (AED) are portable and lightweight devices used to deliver an electric shock through the chest to the heart to bring irregular rhythm of the heart back to normal in patients with sudden cardiac arrest (SCA). In addition, AEDs help in detecting and identifying life-threatening arrhythmias. Almost 95 percent of patients with SCA die within a minute, which has led to increase in the demand for AEDs.